4
Changes in Ownership
C4 Therapeutics, Inc. Filed Acc 0001209191-22-003500
Director acquired 278 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Anderson Kenneth Carl Director | 2022-01-04 | Grant or award | +278 | $31.58 | $8,779 | 85,838 | D |
Loading xslF345X03/doc4.xml…